CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Daewoong Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Daewoong Co Ltd
244, Galmachi-ro, Jungwon-gu
Phone: +82 25508800p:+82 25508800 SEONGNAM, 13211  South Korea Ticker: 003090003090
Business Summary
Daewoong Co Ltd is a Korea-based holding company engaged in the manufacture and sale of pharmaceuticals. The Company operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2034 Dried and dehydrated fruits, vegetables, and soup mixes
8299 Schools and educational services, not elsewhere classified
7373 Computer integrated systems design
2833 Medicinal chemicals and botanical products
6512 Operators of nonresidential buildings
6719 Offices of holding companies, not elsewhere classified
3669 Communications equipment, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Vice Chairman Jae ChunYoon 62 1/1/2021 4/1/2004
Vice President, Director Seong SuPark 46
Internal Auditor Wu BangJeon 61 1/1/2021 5/28/2010
3 additional Officers and Directors records available in full report.

Business Names
Business Name
003090
Daewoong Co., Ltd.

General Information
Number of Employees: 714 (As of 3/31/2000)
Outstanding Shares: 40,890,710 (As of 12/31/2023)
Shareholders: 31,055
Stock Exchange: KRX
Fax Number: +82 220591690


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024